KindlyMD, Inc. (NASDAQ:NAKA) Short Interest Update

KindlyMD, Inc. (NASDAQ:NAKA) was the target of a large drop in short interest in the month of May. As of May 29th, there was short interest totaling 986,003 shares, a drop of 96.8% from the May 14th total of 30,827,459 shares. Based on an average trading volume of 564,906 shares, the days-to-cover ratio is presently 1.7 days. Currently, 7.5% of the company’s stock are sold short.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on NAKA. Weiss Ratings upgraded shares of KindlyMD from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, May 11th. B. Riley Financial cut their price objective on shares of KindlyMD from $40.00 to $20.00 and set a “buy” rating on the stock in a research report on Monday, February 23rd. Maxim Group reduced their price objective on shares of KindlyMD from $60.00 to $30.00 and set a “buy” rating for the company in a research note on Monday, April 6th. TD Cowen assumed coverage on shares of KindlyMD in a research report on Friday, April 10th. They set a “buy” rating and a $40.00 target price for the company. Finally, Wall Street Zen upgraded shares of KindlyMD to a “sell” rating in a research note on Saturday, May 23rd. Three research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $30.00.

Insider Activity at KindlyMD

In related news, CEO David F. Bailey purchased 104,833 shares of KindlyMD stock in a transaction dated Wednesday, May 27th. The stock was purchased at an average cost of $4.84 per share, with a total value of $507,391.72. Following the transaction, the chief executive officer owned 3,120,361 shares in the company, valued at approximately $15,102,547.24. The trade was a 3.48% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Over the last three months, insiders acquired 191,448 shares of company stock valued at $992,908. Insiders own 24.49% of the company’s stock.

Institutional Trading of KindlyMD

Large investors have recently bought and sold shares of the stock. Geode Capital Management LLC raised its holdings in shares of KindlyMD by 76.2% in the second quarter. Geode Capital Management LLC now owns 19,394 shares of the company’s stock worth $484,000 after buying an additional 8,386 shares during the last quarter. Osaic Holdings Inc. purchased a new stake in shares of KindlyMD during the second quarter valued at $215,000. RFG Advisory LLC acquired a new position in shares of KindlyMD in the 3rd quarter valued at $1,019,000. HighTower Advisors LLC acquired a new position in shares of KindlyMD in the 3rd quarter valued at $12,970,000. Finally, Vanguard Group Inc. lifted its position in KindlyMD by 32,737.0% during the 3rd quarter. Vanguard Group Inc. now owns 6,036,750 shares of the company’s stock worth $150,557,000 after acquiring an additional 6,018,366 shares during the period.

KindlyMD Stock Performance

KindlyMD stock opened at $4.40 on Wednesday. The stock has a 50-day moving average of $7.46 and a two-hundred day moving average of $11.93. KindlyMD has a one year low of $4.13 and a one year high of $808.00. The stock has a market cap of $76.56 million, a PE ratio of -0.10 and a beta of 15.84.

KindlyMD (NASDAQ:NAKA) last issued its quarterly earnings results on Wednesday, May 13th. The company reported ($15.20) earnings per share for the quarter. KindlyMD had a negative return on equity of 81.32% and a negative net margin of 7,397.12%.The business had revenue of $2.68 million for the quarter. As a group, sell-side analysts predict that KindlyMD will post -16.8 EPS for the current fiscal year.

KindlyMD Company Profile

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.